CannBioRx Life Company Insiders
| ATNFW Stock | USD 0.01 0.0008 8.89% |
CannBioRx Life employs about 4 people. The company is managed by 14 executives with a total tenure of roughly 10 years, averaging almost 0.0 years of service per executive, having 0.29 employees per reported executive. Recap of CannBioRx Life's management performance can provide insight into the venture performance.
CannBioRx |
CannBioRx Life Management Team Effectiveness
The company has return on total asset (ROA) of (0.5162) % which means that it has lost $0.5162 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.7419) %, meaning that it generated substantial loss on money invested by shareholders. CannBioRx Life's management efficiency ratios could be used to measure how well CannBioRx Life manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to climb to 147.48 in 2025, whereas Return On Tangible Assets are likely to drop (5.18) in 2025. CannBioRx Life reported Non Currrent Assets Other of (15.66 Million) in 2024. Intangibles To Total Assets is likely to climb to 0.70 in 2025, whereas Total Current Assets are likely to drop slightly above 4 M in 2025.Common Stock Shares Outstanding is likely to drop to about 414.2 K in 2025. Net Loss is likely to climb to about (99.7 K) in 2025
CannBioRx Life Workforce Comparison
CannBioRx Life Sciences is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 28.0. CannBioRx Life retains roughly 4.0 in number of employees claiming about 14% of equities under Health Care industry.
CannBioRx Life Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CannBioRx Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on CannBioRx Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, CannBioRx Life insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Marrone Pamela G over a month ago Acquisition by Marrone Pamela G of 32037 shares of CannBioRx Life subject to Rule 16b-3 | ||
Feldmann Marc over six months ago Acquisition by Feldmann Marc of 135377 shares of CannBioRx Life subject to Rule 16b-3 | ||
Mcgovern Jr. Donald A. over a year ago Acquisition by Mcgovern Jr. Donald A. of 15000 shares of CannBioRx Life at 0.67 subject to Rule 16b-3 |
CannBioRx Life Notable Stakeholders
A CannBioRx Life stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CannBioRx Life often face trade-offs trying to please all of them. CannBioRx Life's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CannBioRx Life's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Sir Feldman | CoFounder | Profile | |
| Pr Nanchahal | CoFounder Board | Profile | |
| Pr MD | CoFounder Board | Profile | |
| Sir Feldmann | CoFounder CoChairman | Profile | |
| BA MD | CoFounder CoChairman | Profile | |
| Ozan CFA | CFO Secretary | Profile | |
| CPA CPCU | CFO Director | Profile | |
| MBA LLB | Interim Director | Profile | |
| Jason Assad | Director IR | Profile | |
| Eric Lent | Principal CAO | Profile | |
| Pr Feldmann | Ex CoChairman | Profile | |
| Lawrence Steinman | Ex CoChairman | Profile | |
| Jonathan Rothbard | Chief Officer | Profile | |
| James Woody | CEO Director | Profile |
About CannBioRx Life Management Performance
The success or failure of an entity such as CannBioRx Life Sciences often depends on how effective the management is. CannBioRx Life management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CannBioRx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CannBioRx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (4.93) | (5.18) | |
| Return On Capital Employed | (78.73) | (74.80) | |
| Return On Assets | (3.41) | (3.58) | |
| Return On Equity | 140.46 | 147.48 |
Please note, the imprecision that can be found in CannBioRx Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CannBioRx Life Sciences. Check CannBioRx Life's Beneish M Score to see the likelihood of CannBioRx Life's management manipulating its earnings.
CannBioRx Life Workforce Analysis
Traditionally, organizations such as CannBioRx Life use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CannBioRx Life within its industry.CannBioRx Life Manpower Efficiency
Return on CannBioRx Life Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 5M | |
| Net Loss Per Executive | 1.4M |
Additional Tools for CannBioRx Stock Analysis
When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.